Results 101 to 110 of about 2,233,111 (188)
Vascular Health and Risk Management, 2011 Joanne Kwan1, Wah Wah Htun2, Yili Huang3, Wilson Ko3, Tak W Kwan31Boston University, Boston, MA, USA; 2Lutheran Medical Center, Brooklyn, NY, USA; 3Beth Israel Medical Center, New York, NY, USABackground: The purpose of this study was to examine the ...
Kwan T, Kwan, Huang, Htun, Ko
doaj
BiomedicinesBackground/Objectives: There is wide variability in the individual response to clopidogrel, which depends on CYP2C19 polymorphisms as well as on intrinsic and extrinsic platelet factors.
Raúl Izaguirre-Ávila +6 more
doaj +1 more source
CYP2C19*2 polymorphism and clopidogrel resistance [PDF]
Archivos de cardiolog�a de M�xico (English ed. Internet), 2021 Beuy, Joob, Viroj, Wiwanitkit
openaire +2 more sources
Obesity, Leptin and Thrombosis: Focus on clopidogrel resistance
Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology, 2016 [No abstract available]
openaire +3 more sources
Clopidogrel Resistance: An Emerging Problem
University Heart Journal, 1970 DOI: 10.3329/uhj.v5i2.4552University Heart Journal Vol.5(2) July 2009 pp.50 ...
openaire +2 more sources
The polymorphism of cytochrome P450 CYP2C19 and resistance to clopidogrel. [PDF]
, 2017 The purpose of this study is to investigate the role of CYP2C19 polymorphism on the incidence of adverse cardiovascular events in patients treated with clopidogrel and detection of potential prognostic factors predictive of resistance factors to ...
C. Simoglou
core
A 4-year cross-sectional study on the basic demography and Clopidogrel resistance profile [PDF]
Background and aim: Stroke is a leading cause of death and disability worldwide. Clopidogrel is widely used to prevent recurrent strokes in acute ischemic stroke patients, but clopidogrel resistance remains a significant concern due to various factors.
Humardani, Farizky Martriano +2 more
core +2 more sources
A nightmare of clopidogrel resistance in a resource-limited setting: case report of subacute stent thrombosis. [PDF]
Egypt Heart J, 2023 Pallangyo P +6 more
europepmc +1 more source
Transcriptome-wide map of N6-methyladenosine (m6A) profiling in coronary artery disease (CAD) with clopidogrel resistance. [PDF]
Clin Epigenetics, 2023 Yu R +12 more
europepmc +1 more source
Positive effect of low-activity thromboxane A synthase 1 gene on prognosis in coronary heart disease
Терапевтический архив, 2015 Aim. To analyze the influence of pharmacogenetic factors on the risk of clopidogrel resistance and cardiovascular events during 18-months follow-up. Subjects and methods. Two hundred and fifty patients taking clopidogrel were examined.
F Yu Kopylov +6 more
doaj